Atlas Trials

A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085

Clinical trial NCT07412353 · RECRUITING

Trial details

NCT number
NCT07412353
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Participants
Start date
2026-01-12
Primary completion
2026-11-12
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.